top of page

Pulmonary Board Review Conference Cup Game

Error text

1

First-line treatment of massive PE

.

3 pts

2

Preferred imaging to evaluate for DPLD (be specific)

.

3 pts

3

FEV1/FVC ratio consistent with obstructive lung disease

.

3 pts

4

Medical therapies for loculated empyema

.

4 pts

5

First-line vasopressor for cardiogenic shock

.

4 pts

6

Most common genotype for alpha 1 antitrypsin deficiency

.

5 pts

7

Initial test when you suspect pulmonary hypertension

.

4 pts

8

Pleural fluid enzyme test for TB

.

5 pts

9

Definition of reversible airflow obstruction on PFT's

.

6 pts

10

Medication for aspirin-exacerbated respiratory disease

.

6 pts

11

Criteria for low-dose CT lung cancer screening

.

6 pts

12

Pleural fluid pH and glucose measurements that classify a complicated parapneumonic effusion

.

7 pts

13

ECMO machine parameter that controls CO2 removal

.

7 pts

14

One additional guideline-recommended medication option for severe COPD refractory to triple inhaler therapy to reduce exacerbations

.

10 pts

15

Emphysema pattern amenable to lung volume reduction surgery/intervention

.

14 pts

16

List the three most common causes of chronic cough

.

6 pts

17

List two things that provide mortality benefit in ARDS

.

7 pts

18

Peripheral eosinophil cutoff at which ICS should be considered in COPD

.

7 pts

19

Plateau pressure and tidal volume goals in ARDS

.

7 pts

20

Initial test for cystic fibrosis

.

7 pts

21

Describe the flow-volume loop for vocal cord dysfunction

.

7 pts

22

LABA that new GINA guidelines recommend (in addition to ICS) PRN as step 1 in asthma therapy

.

8 pts

23

Suspect this with asthma, eosinophilia, and moneuritis multiplex

.

8 pts

24

Two FDA approved treatments for IPF

.

9 pts

25

Initial imaging test to evaluate for CTEPH

.

9 pts

26

A large pneumothorax is >__cm at the apex

.

9 pts

27

List the five causes of hypoxemia

.

11 pts

28

List the berlin criteria (4)

.

12 pts

29

List Samter's triad (aspirin exacerbated respiratory disease)

.

14 pts

30

Patients with VTE should be anticoagulated for at least ___ (duration)

.

7 pts

31

Treatment for COP

.

7 pts

32

ILD associated with parietal pleural plaques

.

7 pts

33

List Light's criteria

.

9 pts

34

Monotherapy with ___ (inhaler) increases mortality in asthma patients

.

10 pts

35

Give one example of a condition that can cause normal FEV1, normal FVC, decreased DLCO on PFT's

.

11 pts

36

Next step for 6mm solid nodule in a heavy smoker

.

12 pts

37

Cheyne-Stokes breathing (central sleep apnea) is commonly associated with ___ (comorbidity), to which treatment should be directed

.

12 pts

38

Drug for prevention of high altitude sickness

.

12 pts

39

Name the five categories of pulmonary hypertension

.

12 pts

40

Apnea Hypopnea Index result that defines OSA (__ or more = OSA)

.

14 pts

41

Which type of scleroderma is more associated with ILD and what antibody is most associated with this type

.

15 pts

42

Name a smoking-related DPLD

.

16 pts

43

What are the components of lofgren's syndrome

.

18 pts

44

Cell pattern seen on BAL in HP

.

18 pts

45

What patients with pulmonary hypertension qualify for CCB therapy?

.

22 pts

bottom of page